Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Stem Cells Publisher



Khatami F1 ; Aghaii M1 ; Tehrani FD2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran

Source: Stem Cells in Urology Published:2020


Abstract

Cancer Stem Cells (CSCs) are a minor group of cells in tumors that have self-renewal, differentiation, and tumorigenicity properties. Some known markers such as CD44, CD24, and CD133 on the cell membrane are often used to identify and enrich CSCs in several tumors, including prostate tumors, testis tumors, kidney cancers, and bladder tumors. Actually, CSCs can pass through vessels and shed into the blood and circulate freely to form circulating tumor cells (CTCs). CTCs are suggested as the real-time representers of the tumor. They are the main component of liquid biopsy together with cell free DNA (cfDNA) and exosomes, which are important diagnostic and prognostic markers in uro-oncology. Currently, numerous studies are about the isolation of CSCs from cancers of genito-urinary tracts, especially in prostate, urothelial and kidney cancer origin. Tumor’s progress reveals new ways of finding more effective treatment strategies. In this book chapter, we summarize the current understanding of CSCs and explain the current achievements in cancer stem cell research in urological malignancies. © Springer Nature Switzerland AG 2020.
Related Docs
View other Related Docs
1. Regenerative Medicine in Urology, Stem Cells in Urology (2020)
2. Introduction, Stem Cells in Urology (2020)
3. Current Approaches in Identification and Isolation of Cancer Stem Cells, Journal of Cellular Physiology (2019)
4. Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review, International Journal of Stem Cells (2019)
5. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
6. Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics, Frontiers in Oncology (2019)
7. Update on Immune-Based Therapy Strategies Targeting Cancer Stem Cells, Cancer Medicine (2023)
8. A New Insight Into Cancer Stem Cell Markers: Could Local and Circulating Cancer Stem Cell Markers Correlate in Colorectal Cancer?, Tumor Biology (2016)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Kazem Aghamir Mohammad Ali (9)
Arezoo Rasti (6)
Other Related Docs
9. Tumor Immunology, Clinical Immunology (2022)
10. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
11. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
12. Circulating Tumor Cells and Dnas in Prostate Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
13. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
14. Increased Expression of Cd44 Is Associated With More Aggressive Behavior in Clear Cell Renal Cell Carcinoma, Biomarkers in Medicine (2018)
15. Cancer Stem Cell Research in Iran: Potentials and Challenges, Future Oncology (2017)
16. Glance Into Cancer Stem Cells, Journal of Kerman University of Medical Sciences (2016)
17. Liquid Biopsy As a New Tool for Diagnosis, Monitoring, and Personalized Medicine in Urogenital Cancers, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
18. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
19. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
20. Cancer Stem Cell’S Potential Clinical Implications, International Journal of Cancer Management (2017)
21. Liquid Biopsy in Male Genital Tract: Testis Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
22. Cancer Stem-Like Cell Behavior in Anaplastic Thyroid Cancer: A Challenging Dilemma, Life Sciences (2016)
23. Co-Expression of Putative Cancer Stem Cell Markers Cd44 and Cd133 in Prostate Carcinomas, Pathology and Oncology Research (2017)
24. Smad4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes, Frontiers in Oncology (2021)
25. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
26. U-Shape Incision on Prostate Capsule: New Intraperitoneal Laparoscopic Technique in Simple Prostatectomy: A Case Report, Annals of Medicine and Surgery (2021)
27. Differential Expression of Cancer Stem Cell Markers Aldh1 and Cd133 in Various Lung Cancer Subtypes, Cancer Investigation (2015)
28. Single-Cell Transcriptome Analysis for Cancer and Biology of the Pancreas: A Review on Recent Progress, Frontiers in Genetics (2023)
29. Functionalised Nanomaterials for Eradication of Cscs, a Promising Approach for Overcoming Tumour Heterogeneity, Journal of Drug Targeting (2018)
30. The Molecular Signature of Breast Cancer Metastasis to Bone, Anti-Cancer Drugs (2016)
31. Increased Expression of Aldh1a1 in Prostate Cancer Is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients, Applied Immunohistochemistry and Molecular Morphology (2017)
32. Molecular Docking As a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes, Frontiers in Pharmacology (2022)
33. Cancer Stem Cells and Oral Cancer: Insights Into Molecular Mechanisms and Therapeutic Approaches, Cancer Cell International (2020)
34. Expression of Cd133 Cancer Stem Cell Marker in Melanoma: A Systematic Review and Meta-Analysis, International Journal of Biological Markers (2016)
35. Co-Expression of Cancer Stem Cell Markers Oct4 and Nanog Predicts Poor Prognosis in Renal Cell Carcinomas, Scientific Reports (2018)
36. Transplant and Kidney Repair, Stem Cells in Urology (2020)
37. Investigation of Simvastatin-Induced Apoptosis and Cell Cycle Arrest in Cancer Stem Cells of Mcf-7, Journal of Cancer Research and Therapeutics (2016)
38. Glioblastoma Cancer Stem Cell Biology: Potential Theranostic Targets, Drug Resistance Updates (2019)
39. The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer, Iranian Journal of Biotechnology (2022)
40. Immunopathology and Immunotherapy of Myeloid Leukemia, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
41. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
42. Deciphering Biological Characteristics of Tumorigenic Subpopulations in Human Colorectal Cancer Reveals Cellular Plasticity, Journal of Research in Medical Sciences (2016)
43. Micrornas and Long Non-Coding Rnas As Biomarkers for Polycystic Ovary Syndrome, Journal of Cellular and Molecular Medicine (2022)
44. Thyroid Cancer Research at Endocrinology and Metabolism Research Institute (Emri): A Report of Scientific Activities Between 2005 and 2020, Journal of Diabetes and Metabolic Disorders (2021)
45. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
46. Lessons From the Embryo: An Unrejected Transplant and a Benign Tumor, Stem Cell Reviews and Reports (2021)
47. Local Immunotherapy of Glioblastoma: A Comprehensive Review of the Concept, Journal of Neuroimmunology (2023)
48. Targeting the Metabolism of Cancer Stem Cells by Energy Disruptor Molecules, Critical Reviews in Oncology/Hematology (2022)
49. The Potential Therapeutic Effect of Melatonin on Human Ovarian Cancer by Inhibition of Invasion and Migration of Cancer Stem Cells, Scientific Reports (2017)
50. Human Telomerase Reverse Transcriptase Protein Expression Predicts Tumour Aggressiveness and Survival in Patients With Clear Cell Renal Cell Carcinoma, Pathology (2019)